Literature DB >> 1994892

Monocyte chemotactic proteins from human tumor cells.

D T Graves1, A J Valente.   

Abstract

The production of the monocyte chemoattractant MCP-1 suggests a common mechanism for the recruitment of monocytes/macrophages and provides an explanation for monocyte/macrophage infiltration frequently observed in solid tumors. The regulated production of MCP-1 by non-transformed cells further substantiates the suggestion that MCP-1 is an important inflammatory mediator and is involved in the recruitment of monocytes in a number of pathologic or physiologic conditions.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1994892     DOI： 10.1016/0006-2952(91)90528-d

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


  10 in total

Review 1.  Tumor-associated macrophages in breast cancer.

Authors:  Russell D Leek; Adrian L Harris
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-04       Impact factor: 2.673

2.  Viable head and neck tumor spheroids stimulate in vitro autologous monocyte MCP-1 secretion through soluble substances and CD14/lectin-like receptors.

Authors:  Carla Olsnes; John-Helge Heimdal; Kenneth W Kross; Jan Olofsson; Hans Jørgen Aarstad
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-11-19       Impact factor: 2.503

3.  Chemotherapy of colorectal liver metastases induces a rapid rise in intermediate blood monocytes which predicts treatment response.

Authors:  Dominic Schauer; Patrick Starlinger; Lejla Alidzanovic; Philipp Zajc; Thomas Maier; Alexandra Feldman; Robin Padickakudy; Elisabeth Buchberger; Vanessa Elleder; Andreas Spittler; Judith Stift; Lorand Pop; Birgit Gruenberger; Thomas Gruenberger; Christine Brostjan
Journal:  Oncoimmunology       Date:  2016-03-22       Impact factor: 8.110

4.  Macrophage-targeted photosensitizer conjugate delivered by intratumoral injection.

Authors:  Florencia Anatelli; Pawel Mroz; Qingde Liu; Changming Yang; Ana P Castano; Emilia Swietlik; Michael R Hamblin
Journal:  Mol Pharm       Date:  2006 Nov-Dec       Impact factor: 4.939

5.  Exosomes released by chronic lymphocytic leukemia cells induce the transition of stromal cells into cancer-associated fibroblasts.

Authors:  Jerome Paggetti; Franziska Haderk; Martina Seiffert; Bassam Janji; Ute Distler; Wim Ammerlaan; Yeoun Jin Kim; Julien Adam; Peter Lichter; Eric Solary; Guy Berchem; Etienne Moussay
Journal:  Blood       Date:  2015-06-22       Impact factor: 22.113

6.  Localization of thymidine phosphorylase in advanced gastric and colorectal cancer.

Authors:  Michiya Kobayashi; Ken Okamoto; Toyokazu Akimori; Naoshige Tochika; Tadashi Yoshimoto; Takehiro Okabayashi; Takeki Sugimoto; Keijiro Araki
Journal:  J Mol Histol       Date:  2004-01       Impact factor: 2.611

7.  Myeloid cell receptor LRP1/CD91 regulates monocyte recruitment and angiogenesis in tumors.

Authors:  Nicole D Staudt; Minji Jo; Jingjing Hu; Jeanne M Bristow; Donald P Pizzo; Alban Gaultier; Scott R VandenBerg; Steven L Gonias
Journal:  Cancer Res       Date:  2013-04-30       Impact factor: 12.701

8.  Thymidine phosphorylase and angiogenesis in early stage esophageal squamous cell carcinoma.

Authors:  Youichi Kumagai; Tetsuhiko Tachikawa; Morihiro Higashi; Jun Sobajima; Akemi Takahashi; Kunihiko Amano; Minoru Fukuchi; Kei-Ichiro Ishibashi; Erito Mochiki; Koji Yakabi; Jun-Ichi Tamaru; Hideyuki Ishida
Journal:  Esophagus       Date:  2017-07-24       Impact factor: 4.230

9.  Natural killer T cells infiltrate neuroblastomas expressing the chemokine CCL2.

Authors:  Leonid S Metelitsa; Hong-Wei Wu; Hong Wang; Yujun Yang; Zamir Warsi; Shahab Asgharzadeh; Susan Groshen; S Brian Wilson; Robert C Seeger
Journal:  J Exp Med       Date:  2004-05-03       Impact factor: 14.307

10.  Cancer seeding contributes to intestinal anastomotic dehiscence.

Authors:  Marek Stanczyk; Waldemar L Olszewski; Magdalena Gewartowska; Marek Maruszynski
Journal:  World J Surg Oncol       Date:  2013-11-25       Impact factor: 2.754
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.